Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novavax reports progress on products for H. pylori infection

Nov. 22, 1996

Anti-H. pylori compounds from Fujisawa

Nov. 21, 1996

Chugai describes agents that stimulate gastrointestinal motility

Nov. 21, 1996

Potential of clotrimazole in the treatment of diarrhea

Nov. 20, 1996

ProCyte copper-based compound associated with improvement in ulcerative colitis

Nov. 19, 1996

Promising clinical results for lamivudine in hepatitis

Nov. 15, 1996

Provir effective in acute diarrhea

Nov. 15, 1996

Therapeutic effect of Lilly antioxidant demonstrated in rat model of IBD

Nov. 15, 1996

Roberts to license Lilly gastrointestinal compounds

Nov. 15, 1996

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...